The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Erythropoietin (EPO) Global Market Report 2024, the erythropoietin (EPO) market is expected to show significant growth in the forecast period.

The erythropoietin (EPO) market has experienced rapid growth in recent years and shows promising future prospects. With significant increases in market size and advancements in pharmaceutical research, this blog explores the factors driving this growth, future projections, and major trends that will shape the EPO market.

Recent Market Growth

Market Size and Growth Rate

• 2023 Market Size: $17.29 billion
• 2024 Market Size: $19.25 billion
• CAGR (2023-2024): 11.4%

Historical Growth Drivers

• Patient Education and Awareness: Increased awareness about EPO treatments and their benefits.
• Pharmaceutical Industry Consolidation: Mergers and acquisitions enhancing market capabilities.
• Healthcare Reimbursement Policies: Improved reimbursement policies supporting EPO treatments.
• Market Expansion and Demand Growth: Rising global demand for effective anemia treatments.
• Patent Expiration and Biosimilar Entry: Introduction of biosimilars boosting market competition.

View More On The Erythropoietin (EPO) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

Future Market Prospects

Projected Growth

• 2028 Market Size: $30.92 billion
• CAGR (2024-2028): 12.6%

Future Growth Drivers

• Market Competition and Biosimilar Impact: Increased competition driving innovation and affordability.
• Disease Prevalence Projections: Higher incidence of diseases requiring EPO treatments.
• Healthcare Policy and Reimbursement Changes: Favorable policies enhancing market access.
• Emerging Markets Growth: Expansion in developing regions boosting overall market size.
• Clinical Trials and Research Focus: Ongoing research leading to new applications and treatments.

Major Trends Shaping the Future

Supply Chain Management

• Improvements in supply chain efficiency ensuring timely delivery of EPO products.

Global Expansion and Emerging Markets

• Entry into new geographic regions and markets driving overall growth.

Patient Education and Awareness

• Continued efforts to educate patients on the benefits and availability of EPO treatments.

Reimbursement Policies

• Enhanced policies improving patient access to EPO therapies.

Market Consolidation and Mergers

• Ongoing mergers and acquisitions fostering market stability and growth.

Rising Incidence of Chronic Kidney Diseases

Impact on EPO Market

• Chronic Kidney Disease (CKD) Incidence: Significant driver for EPO demand.
• CDC Report (2021): 15% of U.S. adults, or 37 million people, estimated to have CKD.
• Age Distribution: Higher CKD prevalence in older adults (38% in 65+ age group).

EPO in CKD Treatment

• EPO Role: Used to stimulate red blood cell production in CKD patients, addressing anemia and improving immunity.

Key Players in the EPO Market

• Associated British Foods PLC
• DuPont de Nemours Inc.
• Kerry Group PLC
• Firmenich SA
• Koninklijke DSM NV
• Dyadic International Inc.
• Novozymes A/S
• Endo International PLC
• Chr Hansen Holding A/S
• Advanced Enzyme Technologies Ltd.
• Catalyst Pharmaceuticals Inc.
• Codexis Inc.
• AB Enzymes GmbH
• Brain Biotech AG
• Sunson Industry Group Co. Ltd.

Innovations in Erythropoietin Market

Wanbang’s Yi Bao Breakthrough

• Product: Yi Bao (Human Erythropoietin for Injection)
• Approval: National Medical Products Administration (NMPA) approval in September 2021.
• Application: Treatment of anemia caused by chemotherapy in non-myeloid malignancies.

Market Segmentation

By Product

• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• Other Products

By Drug Class

• Biologics
• Biosimilars

By Application

• Cancer
• Hematology
• Renal Diseases
• Neurology
• Other Applications

Regional Insights

• Largest Market: North America
• Fastest Growing Region: Middle East (forecast period)

Conclusion

The erythropoietin market is set for substantial growth, driven by rising disease prevalence, advancements in healthcare policies, and increased competition from biosimilars. With continuous innovations and expanding global reach, the EPO market is poised to deliver significant benefits to patients worldwide, particularly those suffering from chronic kidney diseases and other related conditions.

Request A Sample Of The Global Erythropoietin (EPO) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3436&type=smp